Douglas Langston
2016
In 2016, Douglas Langston earned a total compensation of $314K as Former Vice President, Finance at Sorrento Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Option Awards | $38,591 |
|---|---|
| Salary | $200,347 |
| Other | $75,104 |
| Total | $314,042 |
Langston received $200.3K in salary, accounting for 64% of the total pay in 2016.
Langston also received $38.6K in option awards and $75.1K in other compensation.
Rankings
In 2016, Douglas Langston's compensation ranked 12,567th out of 14,075 executives tracked by ExecPay. In other words, Langston earned more than 10.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,567 out of 14,075 | 11th |
Division Manufacturing | 4,930 out of 5,489 | 10th |
Major group Chemicals And Allied Products | 1,744 out of 1,895 | 8th |
Industry group Drugs | 1,420 out of 1,538 | 8th |
Industry Biological Products, Except Diagnostic Substances | 258 out of 279 | 8th |
Source: SEC filing on June 26, 2017.
Langston's colleagues
We found five more compensation records of executives who worked with Douglas Langston at Sorrento Therapeutics in 2016.
2016
Henry Ji
Sorrento Therapeutics
Chief Executive Officer
2016
George Ng
Sorrento Therapeutics
Chief Administrative Officer
2016
Jeffrey Su
Sorrento Therapeutics
Chief Operating Officer
2016
Jerome Zeldis
Sorrento Therapeutics
Chief Medical Officer
2016
Kevin Herde
Sorrento Therapeutics